-
Je něco špatně v tomto záznamu ?
Neurotoxicity evoked by organophosphates and available countermeasures
L. Pulkrabkova, B. Svobodova, J. Konecny, T. Kobrlova, L. Muckova, J. Janousek, J. Pejchal, J. Korabecny, O. Soukup
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, přehledy
- MeSH
- acetylcholinesterasa metabolismus MeSH
- cholinesterasové inhibitory toxicita MeSH
- lidé MeSH
- neurotoxické syndromy * etiologie prevence a kontrola MeSH
- neurozánětlivé nemoci MeSH
- organofosfáty MeSH
- otrava organofosfáty * farmakoterapie prevence a kontrola MeSH
- reaktivní formy kyslíku MeSH
- záchvaty MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Organophosphorus compounds (OP) are a constant problem, both in the military and in the civilian field, not only in the form of acute poisoning but also for their long-lasting consequences. No antidote has been found that satisfactorily protects against the toxic effects of organophosphates. Likewise, there is no universal cure to avert damage after poisoning. The key mechanism of organophosphate toxicity is the inhibition of acetylcholinesterase. The overstimulation of nicotinic or muscarinic receptors by accumulated acetylcholine on a synaptic cleft leads to activation of the glutamatergic system and the development of seizures. Further consequences include generation of reactive oxygen species (ROS), neuroinflammation, and the formation of various other neuropathologists. In this review, we present neuroprotection strategies which can slow down the secondary nerve cell damage and alleviate neurological and neuropsychiatric disturbance. In our opinion, there is no unequivocal approach to ensure neuroprotection, however, sooner the neurotoxicity pathway is targeted, the better the results which can be expected. It seems crucial to target the key propagation pathways, i.e., to block cholinergic and, foremostly, glutamatergic cascades. Currently, the privileged approach oriented to stimulating GABAAR by benzodiazepines is of limited efficacy, so that antagonizing the hyperactivity of the glutamatergic system could provide an even more efficacious approach for terminating OP-induced seizures and protecting the brain from permanent damage. Encouraging results have been reported for tezampanel, an antagonist of GluK1 kainate and AMPA receptors, especially in combination with caramiphen, an anticholinergic and anti-glutamatergic agent. On the other hand, targeting ROS by antioxidants cannot or already developed neuroinflammation does not seem to be very productive as other processes are also involved.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004791
- 003
- CZ-PrNML
- 005
- 20230425171723.0
- 007
- ta
- 008
- 230418s2023 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00204-022-03397-w $2 doi
- 035 __
- $a (PubMed)36335468
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Pulkrabkova, Lenka $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic
- 245 10
- $a Neurotoxicity evoked by organophosphates and available countermeasures / $c L. Pulkrabkova, B. Svobodova, J. Konecny, T. Kobrlova, L. Muckova, J. Janousek, J. Pejchal, J. Korabecny, O. Soukup
- 520 9_
- $a Organophosphorus compounds (OP) are a constant problem, both in the military and in the civilian field, not only in the form of acute poisoning but also for their long-lasting consequences. No antidote has been found that satisfactorily protects against the toxic effects of organophosphates. Likewise, there is no universal cure to avert damage after poisoning. The key mechanism of organophosphate toxicity is the inhibition of acetylcholinesterase. The overstimulation of nicotinic or muscarinic receptors by accumulated acetylcholine on a synaptic cleft leads to activation of the glutamatergic system and the development of seizures. Further consequences include generation of reactive oxygen species (ROS), neuroinflammation, and the formation of various other neuropathologists. In this review, we present neuroprotection strategies which can slow down the secondary nerve cell damage and alleviate neurological and neuropsychiatric disturbance. In our opinion, there is no unequivocal approach to ensure neuroprotection, however, sooner the neurotoxicity pathway is targeted, the better the results which can be expected. It seems crucial to target the key propagation pathways, i.e., to block cholinergic and, foremostly, glutamatergic cascades. Currently, the privileged approach oriented to stimulating GABAAR by benzodiazepines is of limited efficacy, so that antagonizing the hyperactivity of the glutamatergic system could provide an even more efficacious approach for terminating OP-induced seizures and protecting the brain from permanent damage. Encouraging results have been reported for tezampanel, an antagonist of GluK1 kainate and AMPA receptors, especially in combination with caramiphen, an anticholinergic and anti-glutamatergic agent. On the other hand, targeting ROS by antioxidants cannot or already developed neuroinflammation does not seem to be very productive as other processes are also involved.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a reaktivní formy kyslíku $7 D017382
- 650 _2
- $a organofosfáty $7 D010755
- 650 _2
- $a neurozánětlivé nemoci $7 D000090862
- 650 12
- $a neurotoxické syndromy $x etiologie $x prevence a kontrola $7 D020258
- 650 12
- $a otrava organofosfáty $x farmakoterapie $x prevence a kontrola $7 D062025
- 650 _2
- $a záchvaty $7 D012640
- 650 _2
- $a cholinesterasové inhibitory $x toxicita $7 D002800
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Svobodova, Barbora $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic
- 700 1_
- $a Konecny, Jan $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic
- 700 1_
- $a Kobrlova, Tereza $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic
- 700 1_
- $a Muckova, Lubica $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic
- 700 1_
- $a Janousek, Jiri $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic
- 700 1_
- $a Pejchal, Jaroslav $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic
- 700 1_
- $a Korabecny, Jan $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic. jan.korabecny@fnhk.cz $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic. jan.korabecny@fnhk.cz $1 https://orcid.org/0000000169777596 $7 xx0119837
- 700 1_
- $a Soukup, Ondrej $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic. ondrej.soukup@fnhk.cz $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic. ondrej.soukup@fnhk.cz $1 https://orcid.org/0000000163768701
- 773 0_
- $w MED00009265 $t Archives of toxicology $x 1432-0738 $g Roč. 97, č. 1 (2023), s. 39-72
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36335468 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425171720 $b ABA008
- 999 __
- $a ok $b bmc $g 1925088 $s 1191000
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 97 $c 1 $d 39-72 $e 20221106 $i 1432-0738 $m Archives of toxicology $n Arch Toxicol $x MED00009265
- LZP __
- $a Pubmed-20230418